Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 1609 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 
 

LETTER TO THE EDITOR Table of Contents   
Year : 2008  |  Volume : 19  |  Issue : 6  |  Page : 985-986
Protective effect of pentoxifylline on contrast induced nephropathy


1 Nemazee Hospital Organ Transplantation Unit, Shiraz University of Medical Sciences, Shiraz, Iran
2 Nemazee Hospital Organ Transplantation Unit, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Renal Transplant, St. Georges Hospital, London, UK

Click here for correspondence address and email
 

How to cite this article:
Roozbeh J, Jahromi AH, Sharifian M, Pakfetrat M, Afshariani R. Protective effect of pentoxifylline on contrast induced nephropathy. Saudi J Kidney Dis Transpl 2008;19:985-6

How to cite this URL:
Roozbeh J, Jahromi AH, Sharifian M, Pakfetrat M, Afshariani R. Protective effect of pentoxifylline on contrast induced nephropathy. Saudi J Kidney Dis Transpl [serial online] 2008 [cited 2020 Nov 25];19:985-6. Available from: https://www.sjkdt.org/text.asp?2008/19/6/985/43480
To the Editor,

Contrast Induced Nephropathy (CIN) is com­monly defined as acute renal failure occurring within 48 hours of exposure to intravenous radiographic contrast that is not attributable to other causes. [1] It is the third most common cause of hospital-acquired acute renal failure, after surgery and hypotension. [2] In most cases it is preventable with sufficient fluid adminis­tration, however an irreversible damage to the kidney might occur.

Ideally, serial creatinine clearances should be measured, but is neither practical nor cost­effective and therefore literature describes the use of isolated measurements of serum crea­tinine levels, even though less sensitive. Con­trast induced acute renal failure has been variably defined as a minimum increase in serum creatinine level from baseline values of 25%-50% or an absolute increase from 0.5 mg/dL to 1.0 mg/dL. (44 to 88 µmol/L). [3]

The exact underlying mechanisms of CIN remain elusive. Experimental studies suggest combination of renal ischemia and direct tubu­lar epithelial cell toxicity as its pathogenesis. Inhibition of renal prostaglandins and nitric oxide synthesis. [4],[5] and contrast media causing oxidative stress and free radical release as possible mechanisms responsible for CIN. [6]

Apart from general agreement on the value of adequate hydration prior to the contrast injec­tion; conflicting and inconsistent reports exist as to the efficacy and safety of different phar­macologic interventions. In a recent meta­analysis, Kelly et al, reviewed effectiveness of different drugs for preventing CIN and could only show overall beneficial effects of N­acetylcysteine and theophylline [7] . They sugges­ted, N-acetylcysteine to be more reno-protec­tive than hydration alone.

Pentoxifylline (PTX) is a methyl-xanthine derivative with multiple haematologic proper­ties. It is commonly used to treat peripheral vascular diseases. PTX improves oxygen deli­very to ischemic tissues through effects of in­creasing intracellular cyclic-AMP in red blood cells, increasing cyclic-AMP in polymorph nuclear cells and decreasing oxygen free radi­cals production. [8],[9] There has been some evi­dence of PTX having free radical-scavenging properties besides limiting the inflammatory response with a reduction in cellular activa­tion, phagocytosis and endothelium adhesion. There are evidences that PTX also reduces the nitric oxide destruction. [9]

Accordingly it could be hypothesized that PTX may have a protective effect on deve­lopment of CIN.

 
   References Top

1.Barrett BJ, Parfrey PS. Prevention of nephro­toxicity induced by radio-contrast agents. N Engl J Med 1994;331:1449-50.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.Tublin ME, Murphy ME, Tessler FN. Current concepts in contrast media-induced nephro­pathy. AJR Am J Roentgenol 1998;171(4): 933-9.  Back to cited text no. 2    
3.Katzberg RW. Urography into 21st century: New contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 1997;204:297-312.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Gleeson TG, Bulugahapitiya S. Contrast­induced nephropathy. AJR Am J Roentgenol 2004;183:1673-89.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]
5.Yokomaku Y, Sugimoto T, Kume S, et al. Asialoerythropoietin prevents contrast-induced nephropathy. J Am Soc Nephrol 2008;19:321-8.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]
6.Jo SH, Koo BK, Park JS, et al. Prevention of radio contrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial-a ran­domized controlled study. Am Heart J 2008; 155:499.  Back to cited text no. 6    
7.Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephro­pathy. Ann Intern Med 2008;148:284-94.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]
8.Stafford-Smith M. Evidence-based renal protection in cardiac surgery. Semin Cardiothorac Vasc Anesth 2005;9:65-76.  Back to cited text no. 8  [PUBMED]  [FULLTEXT]
9.Davila-Esqueda ME, Martinez-Morales F. Pen­toxifylline diminishes the oxidative damage renal tissue induced by streptozotocin in the rat. Exp Diabetes Res 2004;5:245-51.  Back to cited text no. 9    

Top
Correspondence Address:
Maryam Sharifian
Nemazee Hospital Organ Transplantation Unit, Shiraz University of Medical Sciences, Shiraz, Iran

Login to access the Email id


PMID: 18974592

Rights and Permissions



This article has been cited by
1 A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity
Nasiri-Toosi, Z. and Dashti-Khavidaki, S. and Khalili, H. and Lessan-Pezeshki, M.
European Journal of Clinical Pharmacology. 2013; 69(5): 1057-1073
[Pubmed]
2 Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients
Firouzi, A. and Eshraghi, A. and Shakerian, F. and Sanati, H.R. and Salehi, N. and Zahedmehr, A. and Kiani, R. and Maani, M. and Pedarzadeh, A.
International Urology and Nephrology. 2012; 44(4): 1145-1149
[Pubmed]



 

Top
 
 
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  
 


 
    References
 

 Article Access Statistics
    Viewed2077    
    Printed52    
    Emailed0    
    PDF Downloaded609    
    Comments [Add]    
    Cited by others 2    

Recommend this journal